2009
DOI: 10.1210/jc.2009-0345
|View full text |Cite|
|
Sign up to set email alerts
|

Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline

Abstract: Transsexual persons seeking to develop the physical characteristics of the desired gender require a safe, effective hormone regimen that will 1) suppress endogenous hormone secretion determined by the person's genetic/biologic sex and 2) maintain sex hormone levels within the normal range for the person's desired gender. A mental health professional (MHP) must recommend endocrine treatment and participate in ongoing care throughout the endocrine transition and decision for surgical sex reassignment. The endocr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

15
1,056
0
43

Year Published

2011
2011
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 933 publications
(1,130 citation statements)
references
References 124 publications
15
1,056
0
43
Order By: Relevance
“…The standard for treatment in the clinic follows the Standards of Care of the World Professional Association for Transgender Health (WPATH, Coleman et al, 2011), a professional organization in the field of transgender care, and the Clinical Practice Guidelines of the Endocrine Society published in 2009 (Hembree et al, 2009), comprising puberty suppression with gonadotrophin releasing hormone (GnRH) analogues once adolescents start to display the first physical and endocrine changes of puberty (Tanner stage 2-3), followed by cross-sex hormone therapy after the age of 16. From 18 years of age onward, individuals with GD can be referred for sex reassignment surgery.…”
Section: Subjectsmentioning
confidence: 99%
See 1 more Smart Citation
“…The standard for treatment in the clinic follows the Standards of Care of the World Professional Association for Transgender Health (WPATH, Coleman et al, 2011), a professional organization in the field of transgender care, and the Clinical Practice Guidelines of the Endocrine Society published in 2009 (Hembree et al, 2009), comprising puberty suppression with gonadotrophin releasing hormone (GnRH) analogues once adolescents start to display the first physical and endocrine changes of puberty (Tanner stage 2-3), followed by cross-sex hormone therapy after the age of 16. From 18 years of age onward, individuals with GD can be referred for sex reassignment surgery.…”
Section: Subjectsmentioning
confidence: 99%
“…Treatment with cross-sex hormones is continued after sex reassignment surgery. For additional information regarding the standards for diagnostics and treatment of adolescents with GD, see (Hembree et al, 2009;Kreukels and Cohen-Kettenis, 2011). Please see Table 1 for demographic and clinical details of the sample.…”
Section: Subjectsmentioning
confidence: 99%
“…In fact, puberty brings relief for the vast majority of children receiving therapy for GID, because hormone surges propel the development of their brains as well as their bodies and they come to identify with their biological sex. 4,5 Science and ethics trump the current recommendations of the AAP and APA, which amount to conducting an ideology-driven social experiment on vulnerable children and their families. All physicians must work for the reinstatement of the diagnosis and sound treatment of childhood GID.…”
mentioning
confidence: 99%
“…4 It is also striking that the respondents claim that pubertal blockers can lead to stunted growth when the reference they cite actually notes that any slowdown in growth is remedied once puberty ensues, either through discontinuation of blockers or through the addition of cross-sex hormones appropriate for the affirmed gender. 5 Any compromise of fertility would also be reversed should pubertal blockers be stopped with resumption of endogenous puberty. 5 The respondents also raise concern for malignancies with synthetic (cross-sex) hormones; yet, the reference they cite shows no increased risk of cancer during an observation period of up to 30 years and points to the need for long-term studies.…”
mentioning
confidence: 99%
See 1 more Smart Citation